NASDAQ:BPTH
Bio-Path Holdings Stock News
$2.61
-0.0500 (-1.88%)
At Close: May 03, 2024
Bio-Path shares are trading higher after HC Wainwright & Co maintained its Buy rating on the stock.
01:00pm, Monday, 18'th May 2020HC Wainwright & Co. Reiterates Buy on Bio-Path Holdings, Lowers Price Target to $18
11:28am, Monday, 18'th May 2020Edited Transcript of BPTH earnings conference call or presentation 15-May-20 12:30pm GMT
11:11pm, Friday, 15'th May 2020
Q1 2020 Bio Path Holdings Inc Earnings Call
Bio-Path Holdings Q1 EPS $(0.900) Misses $(0.670) Estimate
11:05am, Friday, 15'th May 2020Bio-Path Holdings Reports First Quarter 2020 Financial Results
11:00am, Friday, 15'th May 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drug
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
12:00am, Friday, 15'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 14)
Allogene Therapeutics Inc (...
Bio-Path Highlights Upcoming Presentation On DNAbilize At ASCO May 29
09:20pm, Wednesday, 13'th May 2020Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
09:00pm, Wednesday, 13'th May 2020
HOUSTON, May 13, 2020 -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to.
Bio-Path Holdings to Present at the —…—… American Society of Clinical Oncology Annual ...
12:00am, Wednesday, 13'th May 2020Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020
12:00pm, Friday, 08'th May 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drug
Bio-Path Holdings Presents at 2020 American Association for Cancer Research Annual Meeting
01:00pm, Monday, 27'th Apr 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, tod
Stocks To Watch: Tech Powerhouses Lead Earnings Blitz
12:30pm, Saturday, 25'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
